通过手术前心肺运动检测发现与心力衰竭相关的碳水化合物抗原125升高
R G Davies1, F Fiorini1, D M Bailey2
1Department of Anaesthesia University Hospital of Wales Cardiff UK.
Anaesthesia reports
|August 29, 2025
概括
碳水化合物抗原125的升高通常与癌症有关,可能表明心力衰竭. 心肺运动测试有助于诊断无症状心力衰竭,从而治疗并避免不必要的手术.
科学领域:
- 心脏病学
- 癌症学
- 诊断医学
背景情况:
- 心力衰竭具有显著的术后风险,影响患者的发病率和死亡率.
- 虽然尿酸是传统的心力衰竭生物标志物,但高碳水化合物抗原125 (CA-125) 也可以表明心力衰竭,特别是右侧或保留射出分数.
- CA-125通常与卵巢癌有关,这给诊断带来了挑战.
研究的目的:
- 根据成像和CA-125升高的情况,报告患者的卵巢癌诊断成功.
- 为了说明心肺运动测试 (CPET) 在手术前评估期间识别无症状心力衰竭的有用性.
- 突出CA-125作为心力衰竭管理中的生物标志物的作用,以及其与恶性瘤的区别潜力.
主要方法:
- 一名71岁的妇女接受了CPET作为怀疑卵巢癌的手术前评估的一部分.
- 在CPET测试中发现了显著的无症状心力衰竭.
- 开始进行心脏病学为主导的医疗优化.
主要成果:
- CPET显示显著无症状心力衰竭,促使手术推迟.
- 在优化后,CA-125水平恢复正常,
- 患者避免了严重的腹腔手术.
结论:
- 这一案例强调了在CA-125水平升高的患者中考虑心力衰竭的重要性,尤其是在怀疑恶性瘤时.
- CPET是诊断隐藏疾病如心力衰竭,改善手术前风险分层和患者管理的宝贵工具.
- 生物标志物解释需要全面的临床背景,包括CPET等诊断测试,以避免误诊和不必要的干预.
更多相关视频
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.4K
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
5.9K
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiac Catheterization I: Pre-Procedure Overview
153
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Exercise Stress Test
489
Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
489
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy VI: Nursing Management
32
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
32
